1 terminated, 1 unknown. 1 Early Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Metastatic Well Differentiated Neuroendocrine Neoplasm: new trials by email Literature Review of Metastatic Well Differentiated Neuroendocrine Neoplasm trials Research Report on Metastatic Well Differentiated Neuroendocrine Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial Aiming to Assess the Safety and Activity of the Combination of Cabozantinib Plus Lanreotide in GEP and NET Cabozantinib, Lanreotide - Metastatic Well Differentiated Neuroendocrine Neoplasm, Neuroendocrine Tumors | Phase 2 | Unknown | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 69 | 2020-06-20 | 2021-09-05 |
| 68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors Computed Tomography, Gallium Ga 68-Edotreotide, Positron Emission Tomography - Meningioma, Metastatic Well Differentiated Neuroendocrine Neoplasm | Early Phase 1 | Terminated | M.D. Anderson Cancer Center | 4 | 2017-05-16 | 2021-02-15 |
Neuroendocrine Tumors (2) · Meningioma (1) · Multiple Endocrine Neoplasia Type 1 (1) · von Hippel-Lindau Disease (1)
Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Germ Cell and Embryonal (2) · Neoplasms, Nerve Tissue (2) · Neuroectodermal Tumors (2) · Abnormalities, Multiple (1) · Angiomatosis (1) · Cardiovascular Diseases (1) · Central Nervous System Neoplasms (1) · Ciliopathies (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Genetic Diseases, Inborn (1)
Magnetic Resonance Spectroscopy (1) · cabozantinib (1) · gallium Ga 68 dotatate (1) · lanreotide (1)
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (1) · M.D. Anderson Cancer Center (1)
Italy (1) · United States (1)
Homer A Macapinlac, MD (1) · Sara Pusceddu, MD (1)
PMID 12902325, PMID 15588232, PMID 16801334, PMID 18810319, PMID 21306237, PMID 24405892, PMID 25014687, PMID 25956467, PMID 37752423
2019 (1)